IBC Life Sciences, Hyatt Regency Harborside, Boston, MA
March 28-30, 2006
For four years, attendance at IBC’s Targeting Metabolic Syndrome has steadily increased, as researchers have found this meeting to be an ideal source of scientific updates and valuable networking opportunities. This year, the conference is presented amid the debate over how the Metabolic Syndrome should be regarded by clinicians, regulators and payers – and the implications of this discussion for pharmaceutical companies wanting to target the syndrome per se and its component risk factors. If you are working in metabolic, cardiovascular or inflammatory diseases, make your plans now to attend this leading conference. To register or view full details, visit www.IBCLifeSciences.com/metabolic; or call IBC Life Sciences at 508-616-5550.
|
|